This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Stem cell therapeutics developer iPierian has received $31.5mm in a first round of financing from various backers. Kleiner Perkins Caufield & Byers and Highland Capital Partners together invested $20mm; MPM Capital, $10mm; and FinTech Capital Partners, $1.5mm. Representatives from each of the investors will take seats on the company's board. IPierian was recently formed through the merger of pluripotent stem cell companies iZumi Bio and Pierian to accelerate the development of new cardiovascular, metabolic, and neurology therapeutics.
Gene Therapy, Cell Therapy
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?